Cite
Toxicological implication of prostaglandin transporter SLCO2A1 inhibition by cigarette smoke in exacerbation of lung inflammation
MLA
Ikumi Tamai, et al. “Toxicological Implication of Prostaglandin Transporter SLCO2A1 Inhibition by Cigarette Smoke in Exacerbation of Lung Inflammation.” Toxicology and Applied Pharmacology, vol. 405, May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4b5bd3162e02e69f320a322fe56d88e4&authtype=sso&custid=ns315887.
APA
Ikumi Tamai, Kazuo Kasahara, Hiroki Takashima, Takeo Nakanishi, Ryokichi Honda, Melody N. Shumba, Shiori Sakiyama, & Yoshinobu Nakamura. (2020). Toxicological implication of prostaglandin transporter SLCO2A1 inhibition by cigarette smoke in exacerbation of lung inflammation. Toxicology and Applied Pharmacology, 405.
Chicago
Ikumi Tamai, Kazuo Kasahara, Hiroki Takashima, Takeo Nakanishi, Ryokichi Honda, Melody N. Shumba, Shiori Sakiyama, and Yoshinobu Nakamura. 2020. “Toxicological Implication of Prostaglandin Transporter SLCO2A1 Inhibition by Cigarette Smoke in Exacerbation of Lung Inflammation.” Toxicology and Applied Pharmacology 405 (May). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4b5bd3162e02e69f320a322fe56d88e4&authtype=sso&custid=ns315887.